🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
For the first phase of this study (phase I), the purpose will be to find th...
Status
Completed
Location
BCCA - Vancouver Cancer Centre
Start Date
2012-09-06
Trial ID
NCT01591421
Treatments Being Tested
This phase I trial studies the side effects and best dose of PI3K inhibitor...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2012-05
Trial ID
NCT01540253
This randomized, parallel cohort, two stage, double-blind, placebo-controll...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-09-03
Trial ID
NCT01816594
Treatments Being Tested
The purpose of this study is to determine a maximum tolerated dose and/or r...
Status
Completed
Location
Dana Farber Cancer Institute SC (2)
Start Date
2012-04-20
Trial ID
NCT01468688
The safety, tolerability and recommended phase 2 dose (RP2D) of the combina...
Status
Completed
Location
National Cancer Centre Singapore
Start Date
2011-10-03
Trial ID
NCT01570296
Treatments Being Tested
Preclinical data in lung cancer cell lines showed that EGFR mutation can po...
Status
Completed
Location
Florida Cancer Specialists South
Start Date
2014-03
Trial ID
NCT01487265
Treatments Being Tested
This phase I trial will use the combination of irinotecan and BKM120 in pat...
Status
Completed
Location
University of Kansas Cancer Center
Start Date
2011-02
Trial ID
NCT01304602
Treatments Being Tested
To determine the maximum-tolerated dose (MTD) of BKM120 when administered o...
Status
Terminated
Location
Institut Paoli Calmettes
Start Date
2014-10
Trial ID
NCT02487823
Treatments Being Tested
This is a clinical trial with a molecularly stratified parallel cohort, sin...
Status
Completed
Location
iOMEDICO AG
Start Date
2014-12
Trial ID
NCT02404844
The study will enrol adult female and male patients with BRAF wild-type mel...
Status
Unknown
Location
Department of Dermatology, University Hopsital
Start Date
2015-07
Trial ID
NCT02452294
Treatments Being Tested